Use of negative controls in a prescription sequence symmetry analysis to reduce time-varying bias.

导出原文传递

翻译打印收藏纠错

第一作者： Scott Martin,Vouri

第一单位： Department of Pharmaceutical Outcomes & Policy, University of Florida-College of Pharmacy, Gainesville, Florida, USA.;University of Florida-Center for Drug Evaluation and Safety (CoDES), Gainesville, Florida, USA.

作者： Scott Martin,Vouri ^[1] ; Xinyi,Jiang ^[2] ; Earl J,Morris ^[2] ; Babette A,Brumback ^[3] ; Almut G,Winterstein ^[1]

作者单位： Department of Pharmaceutical Outcomes & Policy, University of Florida-College of Pharmacy, Gainesville, Florida, USA.;University of Florida-Center for Drug Evaluation and Safety (CoDES), Gainesville, Florida, USA. ^[1] Department of Pharmaceutical Outcomes & Policy, University of Florida-College of Pharmacy, Gainesville, Florida, USA. ^[2] University of Florida-Center for Drug Evaluation and Safety (CoDES), Gainesville, Florida, USA.;Department of Biostatistics, University of Florida-College of Public Health & Health Professions College of Medicine, Gainesville, Florida, USA. ^[3]

关键词 pharmacovigilance prescribing cascade prescription sequence symmetry analysis self-controlled

主题词血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);钙通道阻滞药(Calcium Channel Blockers);人类(Humans);处方(Prescriptions);钠钾氯同向转运体抑制剂(Sodium Potassium Chloride Symporter Inhibitors)

DOI 10.1002/pds.5293

PMID 33993606

发布时间 2021-12-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交